Publications

Found 2 results
Filters: Author is J.F. Ji  [Clear All Filters]
2016
S. L. Li, Ma, X. H., Ji, J. F., Li, H., Liu, W., Lu, F. Z., Wu, S. T., and Zhang, Y., miR-1 association with cell proliferation inhibition and apoptosis in vestibular schwannoma by targeting VEGFA, vol. 15, no. 4, p. -, 2016.
Conflicts of interestThe authors declare no conflict of interest.REFERENCESArthurs BJ, Fairbanks RK, Demakas JJ, Lamoreaux WT, et al (2011). A review of treatment modalities for vestibular schwannoma. Neurosurg. Rev. 34: 265-277, discussion 277-279. http://dx.doi.org/10.1007/s10143-011-0307-8 Bartel DP, et al (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297. http://dx.doi.org/10.1016/S0092-8674(04)00045-5 Carmeliet P, et al (2005). VEGF as a key mediator of angiogenesis in cancer. Oncology 69 (Suppl 3): 4-10. http://dx.doi.org/10.1159/000088478 Cayé-Thomasen P, Werther K, Nalla A, Bøg-Hansen TC, et al (2005). VEGF and VEGF receptor-1 concentration in vestibular schwannoma homogenates correlates to tumor growth rate. Otol. Neurotol. 26: 98-101. http://dx.doi.org/10.1097/00129492-200501000-00017 Cech TR, Steitz JA, et al (2014). The noncoding RNA revolution-trashing old rules to forge new ones. Cell 157: 77-94. http://dx.doi.org/10.1016/j.cell.2014.03.008 Chen CZ, et al (2005). MicroRNAs as oncogenes and tumor suppressors. N. Engl. J. Med. 353: 1768-1771. http://dx.doi.org/10.1056/NEJMp058190 Chen H, Zhang X, Zhang Z, Yang T, et al (2014). The role of NF2 gene mutations and pathogenesis-related proteins in sporadic vestibular schwannomas in young individuals. Mol. Cell. Biochem. 392: 145-152. http://dx.doi.org/10.1007/s11010-014-2011-9 Cioffi JA, Yue WY, Mendolia-Loffredo S, Hansen KR, et al (2010). MicroRNA-21 overexpression contributes to vestibular schwannoma cell proliferation and survival. Otol. Neurotol. 31: 1455-1462. Dilwali S, Roberts D, Stankovic KM, et al (2015). Interplay between VEGF-A and cMET signaling in human vestibular schwannomas and schwann cells. Cancer Biol. Ther. 16: 170-175. http://dx.doi.org/10.4161/15384047.2014.972765 Han C, Zhou Y, An Q, Li F, et al (2015). MicroRNA-1 (miR-1) inhibits gastric cancer cell proliferation and migration by targeting MET. Tumour Biol. 36: 6715-6723. http://dx.doi.org/10.1007/s13277-015-3358-6 Jacob A, Lee TX, Neff BA, Miller S, et al (2008). Phosphatidylinositol 3-kinase/AKT pathway activation in human vestibular schwannoma. Otol. Neurotol. 29: 58-68. http://dx.doi.org/10.1097/mao.0b013e31816021f7 Jiang S, Zhao C, Yang X, Li X, et al (2016). miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression. Int. J. Mol. Med. 38: 113-122. Koutsimpelas D, Bjelopavlovic M, Yetis R, Frauenknecht K, et al (2012). The VEGF/VEGF-R axis in sporadic vestibular schwannomas correlates with irradiation and disease recurrence. ORL J. Otorhinolaryngol. Relat. Spec. 74: 330-338. http://dx.doi.org/10.1159/000346238 Liu R, Li J, Lai Y, Liao Y, et al (2015). Hsa-miR-1 suppresses breast cancer development by down-regulating K-ras and long non-coding RNA MALAT1. Int. J. Biol. Macromol. 81: 491-497. http://dx.doi.org/10.1016/j.ijbiomac.2015.08.016 Mataki H, Enokida H, Chiyomaru T, Mizuno K, et al (2015). Downregulation of the microRNA-1/133a cluster enhances cancer cell migration and invasion in lung-squamous cell carcinoma via regulation of Coronin1C. J. Hum. Genet. 60: 53-61. http://dx.doi.org/10.1038/jhg.2014.111 Nasser MW, Datta J, Nuovo G, Kutay H, et al (2008). Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. J. Biol. Chem. 283: 33394-33405. http://dx.doi.org/10.1074/jbc.M804788200 Osaka E, Yang X, Shen JK, Yang P, et al (2014). MicroRNA-1 (miR-1) inhibits chordoma cell migration and invasion by targeting slug. J. Orthop. Res. 32: 1075-1082. http://dx.doi.org/10.1002/jor.22632 Shi H, Ji Y, Zhang D, Liu Y, et al (2015). MiR-135a inhibits migration and invasion and regulates EMT-related marker genes by targeting KLF8 in lung cancer cells. Biochem. Biophys. Res. Commun. 465: 125-130. http://dx.doi.org/10.1016/j.bbrc.2015.07.145 Taniguchi K, Sakai M, Sugito N, Kumazaki M, et al (2016). PTBP1-associated microRNA-1 and -133b suppress the Warburg effect in colorectal tumors. Oncotarget 7: 18940-18952. Torres-Martin M, Lassaletta L, de Campos JM, Isla A, et al (2013). Global profiling in vestibular schwannomas shows critical deregulation of microRNAs and upregulation in those included in chromosomal region 14q32. PLoS One 8: e65868. http://dx.doi.org/10.1371/journal.pone.0065868 Wang F, Song G, Liu M, Li X, et al (2011). miRNA-1 targets fibronectin1 and suppresses the migration and invasion of the HEp2 laryngeal squamous carcinoma cell line. FEBS Lett. 585: 3263-3269. http://dx.doi.org/10.1016/j.febslet.2011.08.052 Wang X, Huang Y, Zhuang H, Qian Y, et al (2015). Downregulation of microRNA-1 is associated with poor prognosis in hepatocellular carcinoma. Clin. Lab. 61: 1331-1336. Wu YY, Chen YL, Jao YC, Hsieh IS, et al (2014). miR-320 regulates tumor angiogenesis driven by vascular endothelial cells in oral cancer by silencing neuropilin 1. Angiogenesis 17: 247-260. http://dx.doi.org/10.1007/s10456-013-9394-1 Xiao H, Zeng J, Li H, Chen K, et al (2015). MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis. Oncotarget 6: 13201-13215. http://dx.doi.org/10.18632/oncotarget.3915 Xu K, Zhao YC, et al (2016). MEF2D/Wnt/β-catenin pathway regulates the proliferation of gastric cancer cells and is regulated by microRNA-19. Tumour Biol. 37: 9059-9069. http://dx.doi.org/10.1007/s13277-015-4766-3 Yamamoto N, Nishikawa R, Chiyomaru T, Goto Y, et al (2015). The tumor-suppressive microRNA-1/133a cluster targets PDE7A and inhibits cancer cell migration and invasion in endometrial cancer. Int. J. Oncol. 47: 325-334. Zhu K, Wang W, et al (2016). Green tea polyphenol EGCG suppresses osteosarcoma cell growth through upregulating miR-1. Tumour Biol. 37: 4373-4382. http://dx.doi.org/10.1007/s13277-015-4187-3